Profile data is unavailable for this security.
About the company
Alphamab Oncology is an investment holding company primarily engaged in the biopharmaceutical business. The Company is a full-industry chain enterprise specializing in research, development, manufacture, and commercialization of innovative tumor immunobiology macromolecular targeted drugs. The Company has bio-innovation drug development technology platform, including protein engineering platform, multi-functional antibody development platform and antibody screening platform. The Company operates its businesses in both domestic and overseas markets.
- Revenue in HKD (TTM)235.09m
- Net income in HKD-226.30m
- Incorporated2018
- Employees435.00
- LocationAlphamab OncologyNo. 175Fangzhou Road, Suzhou Industrial ParkSuzhou 215125ChinaCHN
- Phone+86 51 262850800
- Websitehttps://www.alphamabonc.com/en/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jacobio Pharmaceuticals Group Co Ltd | 68.26m | -385.90m | 1.17bn | 301.00 | -- | 1.02 | -- | 17.12 | -0.4992 | -0.4992 | 0.0883 | 1.46 | 0.0419 | -- | 5.21 | 226,766.00 | -23.66 | -45.76 | -26.86 | -49.30 | 5.04 | -- | -565.36 | -372.22 | -- | -- | 0.1636 | -- | -33.66 | -- | 3.43 | -- | 19.18 | -- |
| CStone Pharmaceuticals | 498.43m | -394.62m | 1.44bn | 230.00 | -- | 2.93 | -- | 2.89 | -0.3128 | -0.3128 | 0.3946 | 0.3823 | 0.2811 | 2.44 | 3.72 | 2,167,086.00 | -22.25 | -54.76 | -48.85 | -81.68 | 65.60 | -- | -79.17 | -301.62 | 1.44 | -- | 0.4431 | -- | -3.64 | -- | 59.32 | -- | 52.42 | -- |
| TOT Biopharm International Co Ltd | 838.84m | -40.57m | 1.52bn | 551.00 | -- | 2.06 | 290.79 | 1.81 | -0.056 | -0.056 | 1.16 | 0.9548 | 0.5808 | 1.87 | 8.03 | 1,522,394.00 | -2.81 | -20.01 | -3.72 | -25.21 | 73.53 | 74.74 | -4.84 | -68.53 | 1.48 | -4.60 | 0.3348 | -- | 76.54 | 81.88 | 24.36 | -- | 21.04 | -- |
| Wuhan YZY Biopharma Co Ltd | 0.00 | -206.00m | 1.57bn | 123.00 | -- | 11.42 | -- | -- | -1.11 | -1.11 | 0.00 | 0.7076 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | 1.41 | -100.12 | 0.4138 | -- | -- | -- | -1.50 | -- | -- | -- |
| Frontage Holdings Corp | 2.03bn | 84.45m | 1.59bn | 1.76k | 19.09 | 0.5928 | 4.39 | 0.7821 | 0.0409 | 0.0409 | 0.981 | 1.32 | 0.463 | 60.63 | 5.32 | 1,154,264.00 | 1.91 | 4.46 | 2.33 | 5.28 | 30.17 | 34.00 | 4.13 | 9.92 | 1.39 | 4.09 | 0.296 | 0.00 | 3.79 | 25.61 | -58.00 | -0.7826 | 40.43 | -- |
| Hua Medicine | 82.32m | -226.99m | 1.59bn | 177.00 | -- | 13.62 | -- | 19.36 | -0.2322 | -0.2322 | 0.0843 | 0.1109 | 0.0538 | 1.69 | 13.03 | 465,099.80 | -14.84 | -25.61 | -17.56 | -28.81 | 48.78 | -- | -275.73 | -1,654.70 | 6.06 | -- | 0.6238 | -- | 335.31 | -- | -3.80 | -- | 14.07 | -- |
| Mabpharm Ltd | 93.66m | -224.97m | 1.63bn | 347.00 | -- | 7.39 | -- | 17.39 | -0.0546 | -0.0546 | 0.0227 | 0.0534 | 0.0893 | 0.1176 | 6.02 | 269,914.80 | -21.44 | -21.42 | -28.92 | -27.49 | 86.32 | -- | -240.19 | -486.40 | 0.7596 | -19.03 | 0.5591 | -- | 55.87 | -- | 0.694 | -- | -26.85 | -- |
| Immunotech Biopharm Ltd | 0.00 | -359.79m | 1.74bn | 211.00 | -- | 9.32 | -- | -- | -0.6992 | -0.6992 | 0.00 | 0.3626 | 0.00 | -- | -- | 0.00 | -38.88 | -37.42 | -50.88 | -45.48 | -- | -- | -- | -- | 1.03 | -2.51 | 0.4327 | -- | -- | -- | -5.25 | -- | -8.46 | -- |
| Laekna Inc | 0.00 | -396.32m | 1.93bn | 89.00 | -- | 2.23 | -- | -- | -3.28 | -3.28 | 0.00 | 2.21 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -5.28 | 0.0655 | -- | -- | -- | 52.81 | -- | -- | -- |
| Alphamab Oncology | 235.09m | -226.30m | 2.27bn | 435.00 | -- | 1.26 | -- | 9.65 | -0.2353 | -0.2353 | 0.2449 | 1.86 | 0.1028 | 0.7705 | 19.34 | 540,431.20 | -9.90 | -18.72 | -11.69 | -21.94 | 74.75 | -- | -96.26 | -415.55 | 5.55 | -- | 0.1333 | -- | 31.12 | -- | 35.35 | -- | -13.12 | -- |
| Abbisko Cayman Ltd | 20.48m | -463.77m | 2.28bn | 258.00 | -- | 1.07 | -- | 111.08 | -0.7166 | -0.7166 | 0.0316 | 3.03 | 0.0083 | -- | 1.40 | 79,384.77 | -18.74 | -- | -19.67 | -- | 100.00 | -- | -2,264.34 | -- | -- | -- | 0.0177 | -- | -- | -- | 12.92 | -- | -- | -- |
| CARsgen Therapeutics Holdings Ltd | 0.00 | -803.56m | 2.59bn | 516.00 | -- | 1.34 | -- | -- | -1.45 | -1.45 | 0.00 | 3.36 | 0.00 | -- | -- | 0.00 | -29.79 | -- | -32.14 | -- | -- | -- | -- | -- | 9.54 | -- | 0.0452 | -- | -- | -- | 16.19 | -- | -- | -- |
| Biocytogen Pharmaceuticals Beijng Co Ltd | 770.37m | -411.51m | 2.97bn | 1.07k | -- | 3.51 | -- | 3.85 | -1.03 | -1.03 | 1.93 | 2.11 | 0.2732 | 16.21 | 5.74 | 722,674.30 | -14.59 | -- | -18.88 | -- | 70.59 | -- | -53.42 | -- | 1.24 | -21.30 | 0.4077 | -- | 34.28 | -- | 36.38 | -- | -- | -- |
Data as of Jul 04 2024. Currency figures normalised to Alphamab Oncology's reporting currency: Hong Kong Dollar HKD
7.90%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 06 Jun 2024 | 23.84m | 2.47% |
| Zhong Ou Asset Management Co., Ltdas of 31 Dec 2023 | 16.02m | 1.66% |
| GF Fund Management Co., Ltd.as of 31 Dec 2023 | 11.95m | 1.24% |
| First Seafront Fund Management Co., Ltd.as of 31 Dec 2023 | 8.52m | 0.88% |
| BlackRock Fund Advisorsas of 06 Jun 2024 | 6.49m | 0.67% |
| Bosera Asset Management Co., Ltd.as of 31 Dec 2023 | 3.31m | 0.34% |
| China Asset Management Co., Ltd.as of 31 Dec 2023 | 2.19m | 0.23% |
| BlackRock Advisors (UK) Ltd.as of 06 Jun 2024 | 1.77m | 0.18% |
| Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)as of 31 Dec 2023 | 1.18m | 0.12% |
| E Fund Asset Management Co. Ltd.as of 31 Dec 2023 | 968.00k | 0.10% |
More ▼
Data from 31 Dec 2023 - 27 Jun 2024Source: FactSet Research Systems Inc.
